Date published: 2026-5-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

Dopey-1 Inhibitors

Dopey-1 inhibitors represent a distinctive class of chemicals focused on the modulation of the Dopey-1 protein, which plays a significant role in cellular processes. The name "Dopey-1" derives from the unique and somewhat whimsical nomenclature often employed in the early stages of genetic research, where scientists named genes based on observed phenotypes or functions in model organisms. Dopey-1 inhibitors are developed through rigorous scientific methods, including structure-activity relationship (SAR) studies, which allow chemists to understand how the molecular structures of these inhibitors interact with the Dopey-1 protein. These studies involve the synthesis of various derivatives of a lead compound and testing these derivatives for their ability to inhibit Dopey-1 activity. The goal is to identify molecules that exhibit high specificity and efficacy in inhibiting the function of Dopey-1, thereby influencing the cellular pathways in which Dopey-1 is involved.

The development of Dopey-1 inhibitors also relies heavily on computational modeling and molecular docking studies. These methods use computer simulations to predict how the inhibitors will fit into the active site of the Dopey-1 protein, much like a key fits into a lock. This approach can identify potential interactions between the inhibitor and specific amino acids within the protein, providing insights into the binding affinity and overall effectiveness of the inhibitor. Furthermore, advanced techniques such as cryo-electron microscopy and X-ray crystallography can be employed to obtain high-resolution images of the Dopey-1-inhibitor complexes, offering a detailed view of the molecular interactions at play. Through these sophisticated techniques, scientists can design and optimize Dopey-1 inhibitors with enhanced precision, leading to more efficient modulation of the Dopey-1 protein's activity within cells. This comprehensive approach underscores the multifaceted strategy in developing Dopey-1 inhibitors, encompassing both theoretical knowledge and practical experimentation to explore the intricate dynamics between small molecules and their biological targets.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Disrupts Golgi structure and function, potentially affecting Dopey-1-related trafficking.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

An ionophore that alters Golgi processing and endosomal functions.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

Disrupts microtubule dynamics, impacting vesicular transport.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

Inhibits dynamin, affecting endocytosis and vesicular trafficking.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$165.00
$486.00
64
(4)

Disrupts actin filaments, potentially influencing vesicle movement.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Inhibits N-linked glycosylation, affecting Golgi function.

Golgicide A

1005036-73-6sc-215103
sc-215103A
5 mg
25 mg
$191.00
$683.00
11
(1)

Specifically disrupts Golgi function, potentially impacting Dopey-1 activity.

Pitstop 2

1419320-73-2sc-507418
10 mg
$360.00
(0)

Inhibits clathrin-mediated endocytosis, affecting vesicular transport.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

PI3 kinase inhibitor, impacting endosomal trafficking.

Vinblastine

865-21-4sc-491749
sc-491749A
sc-491749B
sc-491749C
sc-491749D
10 mg
50 mg
100 mg
500 mg
1 g
$102.00
$235.00
$459.00
$1749.00
$2958.00
4
(0)

Alters microtubule dynamics, impacting intracellular transport.